CanSino Biologics Inc. (6185.HK) HKSE

42.48

+0.08(+0.19%)

Updated at October 24 04:08PM

Currency In HKD

Valuation

Market Cap7.33B
Enterprise Value7.78B
P/E Ratio-137.73
PEG Ratio-5.77
Price/Sales Ratio14.99
Price/Book Ratio4.69
Enterprise/Revenue15.29
Enterprise/EBITDA-98.83

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.18
Operating Margin-0.26

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.03

Income Statement

Revenue846.34M
Revenue/Share2.99
Gross Profit601.91M
EBITDA-134.84M
Net Income-378.88M
Diluted EPS-1.53

Balance Sheet

Total Cash3.27B
Total Cash/Share6.27
Total Debt1.89B
Total Debt/Equity0.39
Current Ratio2.57
Book Value Per Share15.89

Price History

52-Week Change70.95
52-Week High56.55
52-Week Low25
Moving Average 50 Days49.55
Moving Average 200 Days38.2

Statistics

Average Volume2.11M
Shares Outstanding349.87M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.33
Last Split FactorN/A
Last Split DateN/A